A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, Vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Kemse, Nisha G ^a   Kale, Anvita A ^a   Joshi, Sadhana R ^a  

^a Bharati Vidyapeeth Deemed University   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; FEMALE; FETUS WEIGHT; LIVER WEIGHT; MATERNAL HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PLACENTA WEIGHT; PREECLAMPSIA; RAT; RAT MODEL; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; ANIMAL; BLOOD; DRUG COMBINATION; HYPERTENSION, PREGNANCY-INDUCED; METABOLISM; PREGNANCY; WISTAR RAT;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; FEMALE; FOLIC ACID; HYPERTENSION, PREGNANCY-INDUCED; OXIDATIVE STRESS; PREGNANCY; RATS; RATS, WISTAR; VITAMIN B 12; VITAMINS;

EID: 84915819123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111902     Document Type: Article

References (110)

1. Henao DE, Saleem MA (2013) Proteinuria in preeclampsia from a podocyte injury perspective. Curr Hypertens Rep 15: 600-605.
2. Roberts JM, Escudero C (2012) The placenta in preeclampsia. Pregnancy Hypertens 2: 72-83.
3. Chaturvedi S, Randive B, Mistry N (2013) Availability of treatment for eclampsia in public health institutions in Maharashtra, India. J Health Popul Nutr 31: 86-95.
4. Jido TA, Yakasai IA (2013) Preeclampsia: a review of the evidence. Ann Afr Med 12: 75-85.
5. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L (2010) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 4: CD001059.
6. Atallah AN, Hofmeyr GJ, Duley L (2002) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev (1): CD001059.
7. Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, et al.(2006) World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 195: 639-649.
8. Oken E, Ning Y, Rifas-Shiman SL, Rich-Edwards JW, Olsen SF, et al. (2007) Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol 17: 663-668.
9. Fowles ER, Walker LO, Marti CN, Ruiz RJ, Wommack J, et al. (2012) Relationships among maternal nutrient intake and placental biomarkers during the 1st trimester in low-income women. Arch Gynecol Obstet 285: 891-899.
10. Yanez P, Vásquez CJ, Rodas L, Durán A, Chedraui P, et al. (2013) Erythrocyte folate content and serum folic acid and homocysteine levels in preeclamptic primigravidae teenagers living at high altitude. Arch Gynecol Obstet 288: 1011-1015.
11. Tang Z, Buhimschi IA, Buhimschi CS, Tadesse S, Norwitz E, et al. (2013) Decreased levels of folate receptor-b and reduced numbers of fetal macrophages (Hofbauer cells) in placentas from pregnancies with severe pre-eclampsia. Am J Reprod Immunol 70: 104-115.
12. Mujawar SA, Patil VW, Daver RG (2011) Study of serum homocysteine, folic Acid and vitamin B12 in patients with preeclampsia. Indian J Clin Biochem 26: 257-260.
13. Ogundipe O, Hoyo C, Østbye T, Oneko O, Manongi R, et al. (2012) Factors associated with prenatal folic acid and iron supplementation among 21, 889 pregnant women in Northern Tanzania: a cross-sectional hospital-based study. BMC Public Health 12: 481.
14. Bergen NE, Jaddoe VW, Timmermans S, Hofman A, Lindemans J, et al. (2012) Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG 119: 739-751.
15. 12, and homocysteine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 153: 474-480.
16. Rajkovic A, Catalano PM, Malinow MR (1997) Elevated homocysteine levels with preeclampsia. Obstet Gynecol 90: 168-171.
17. Walker MC, Finkelstein SA, Rennicks White R, Shachkina S, Smith GN, et al. (2011) The Ottawa and Kingston (OaK) Birth Cohort: development and achievements. J Obstet Gynaecol Can 33: 1124-1133.
18. Wen SW, Chen XK, Rodger M, White RR, Yang Q, et al. (2008) Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 198: 45. e1-e7.
19. Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM (2006) Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol 164: 470-477.
20. Hernández-Díaz S, Werler MM, Louik C, Mitchell AA (2002) Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol 156: 806-812.
21. Li Z, Ye R, Zhang L, Li H, Liu J, et al. (2013) Folic acid supplementation during early pregnancy and the risk of gestational hypertension and preeclampsia. Hypertension 61: 873-879.
22. Ray JG, Mamdani MM (2002) Association between folic acid food fortification and hypertension or preeclampsia in pregnancy. Arch Intern Med 162: 1776-1777.
23. Thériault S, Giguère Y, Massé J, Lavoie SB, Girouard J, et al. (2013) Absence of association between serum folate and preeclampsia in women exposed to food fortification. Obstet Gynecol 122: 345-351.
24. Morris CD, Jacobson SL, Anand R, Ewell MG, Hauth JC, et al. (2001) Nutrient intake and hypertensive disorders of pregnancy: Evidence from a large prospective cohort. Am J Obstet Gynecol 184: 643-651.
25. Mahomed K, Williams MA, King IB, Mudzamiri S, Woelk GB (2007) Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res 56: 37-50.
26. Poprawski G, Wender-Ozegowska E, Zawiejska A, Brazert J (2012) Modern methods of early screening for preeclampsia and pregnancy-induced hyper-tension-a review. Ginekol Pol 83: 688-693.
27. Jones ML, Mark PJ, Waddell BJ (2014) Maternal dietary omega-3 fatty acids and placental function. Reproduction [Epub ahead of print].
28. De Giuseppe R, Roggi C, Cena H (2014) n-3 LC-PUFA supplementation: effects on infant and maternal outcomes. Eur J Nutr [Epub ahead of print].
29. Zhang Z, Gao Y, Zhang L, Jia L, Wang P, et al. (2013) Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia. Hypertens Pregnancy 32: 270-280.
30. Xie C, Yao MZ, Liu JB, Xiong LK (2011) A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 56: 550-559.
31. Laresgoiti-Servitje E (2013) A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol 94: 247-257.
32. 12 is associated with birth outcome: an Indian pregnant women study. Eur J Clin Nutr [Epub ahead of print].
33. Erickson KL, Medina EA, Hubbard NE (2000) Micronutrients and innate immunity. J Infect Dis 182 Suppl 1: S5-S10.
34. Thurnham DI (2004) An overview of interactions between micronutrients and of micronutrients with drugs, genes and immune mechanisms. Nutr Res Rev 17: 211-40.
35. Wintergerst ES, Maggini S, Hornig DH (2007) Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 51: 301-323.
36. Kulkarni A, Chavan-Gautam P, Mehendale S, Yadav H, Joshi S (2011a) Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol 30: 79-84.
37. Calder PC, Kew S (2002) The immune system: a target for functional foods? Br J Nutr 88 Suppl 2: S165-S177.
38. Kulkarni A, Mehendale S, Pisal H, Killari A, Dangat K, et al. (2011b) Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia. Clin Nutr 30: 60-64.
39. Mehendale S, Kilari A, Dangat K, Taralekar V, Mahadik S, et al. (2008) Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. International Journal of Gynecology and Obstetrics 100: 234-238.
40. Ma RQ, Sun MN, Yang Z (2011) Inhibition of nitric oxide synthase lowers fatty acid oxidation in preeclampsia-like mice at early gestational stage. Chin Med J (Engl) 124: 3141-3147.
41. Ma RQ, Sun MN, Yang Z (2010) Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model. Chin Med J (Engl) 123: 707-712.
42. Brown C, McFarlane-Anderson N, Alexander-Lindo R, Bishop K, Dasgupta T, et al. (2013) The effects of S-nitrosoglutathione and S-nitroso-N-acetyl-D, L-penicillamine in a rat model of pre-eclampsia. J Nat Sci Biol Med 4: 330-335.
43. Nassar AH, Masrouha KZ, Itani H, Nader KA, Usta IM (2012) Effects of sildenafil in Nv-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model. Am J Perinatol 29: 429-434.
44. Neerhof MG, Synowiec S, Khan S, Thaete LG (2011) Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat. Hypertens Pregnancy 30: 28-36.
45. Mayr AJ, Lederer W, Wolf HJ, Dünser M, Pfaller K, et al. (2005) Morphologic changes of the uteroplacental unit in preeclampsia-like syndrome in rats. Hypertens Pregnancy 24: 29-37.
46. Takei H, Iizuka S, Yamamoto M, Takeda S, Yamamoto M, et al. (2007) The herbal medicine Tokishakuyakusan increases fetal blood glucose concentrations and growth hormone levels and improves intrauterine growth retardation induced by N(omega)-nitro-L-arginine methyl ester. J Pharmacol Sci 104: 319-328.
47. Reeves P, Nielsen F, Fahey G Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.
48. Dhobale MV, Wadhwani N, Mehendale SS, Pisal HR, Joshi SR (2011) Reduced levels of placental long chain polyunsaturated fatty acids in preterm deliveries, Prostaglandins Leukot. Essent. Fatty Acids 85: 149-153.
49. Sable PS, Dangat KD, Joshi AA, Joshi SR (2012) Maternal omega 3 fatty acid supplementation during Pregnancy to a micronutrient-imbalanced diet protects Postnatal reduction of brain neurotrophins in the rat Offspring. Neuroscience 217: 46-55.
50. Sable PS, Kale AA, Joshi SR (2013) Prenatal omega 3 fatty acid supplementation to a micronutrient imbalanced diet protects brain neurotro-phins in both the cortex and hippocampus in the adult rat offspring. Metabolism Clinical And Experimental 62: 1607-1622.
51. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, et al. (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A 28; 95: 4882-4887.
52. Zhou Q, Shen J, Zhou G, Shen L, Zhou S, et al. (2013) Effects of magnesium sulfate on heart rate, blood pressure variability and baroreflex sensitivity in preeclamptic rats treated with L-NAME. Hypertens Pregnancy 32: 422-431.
53. Sung JH, Jo YS, Kim SJ, Ryu JS, Kim MC, et al. (2013) Effect of Lutein on L-NAME-Induced Hypertensive Rats. Korean J Physiol Pharmacol 17: 339-345.
54. Adamcova M, Ruzickova S, Simko F (2013) Multiplexed immunoassays for simultaneous quantification of cardiovascular biomarkers in the model of H (G)-nitro-L-arginine methylester (L-NAME) hypertensive rat. J Physiol Pharmacol 64: 211-217.
55. Gad HI (2013) The potential role of anti tumor necrosis factor-alpha antibodies on some renal functions and vasoregulatory factors in preeclamptic pregnant Wistar rats. Saudi Med J 34: 490-496.
56. + channels. Proc Natl Acad Sci U S A 110: 4816-4821.
57. Nilsson A, Radeborg K, Salo I, Björck I (2012) Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 11: 99.
58. Xun P, Liu K, Loria CM, Bujnowski D, Shikany JM, et al. (2012) Folate intake and incidence of hypertension among American young adults: a 20-y follow-up study. Am J Clin Nutr 95: 1023-1030.
59. McMahon JA, Skeaff CM, Williams SM, Green TJ (2007) Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr 137: 1183-1187.
60. Salvig JD, Olsen SF, Secher NJ (1996) Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. Br J Obstet Gynaecol 103: 529-533.
61. de Moura RS, Resende AC, Moura AS, Maradei MF (2007) Protective action of a hydroalcoholic extract of a vinifera grape skin on experimental preeclampsia in rats. Hypertens Pregnancy 26: 89-100.
62. Gairard A, Lopez-Miranda V, Pernot F, Beck JF, Coumaros G, et al. (2004) Effect of i1 imidazoline receptor agonist, moxonidine, in nitric oxide-deficient hypertension in pregnant rats. J Cardiovasc Pharmacol 43: 731-736.
63. Fernández Celadilla L, Carbajo Rueda M, Muñoz Rodríguez M (2005) Prolonged inhibition of nitric oxide synthesis in pregnant rats: effects on blood pressure, fetal growth and litter size. Arch Gynecol Obstet 271: 243-248.
64. Isler CM, Bennett WA, Rinewalt AN, Cockrell KL, Martin JN, et al. (2003) Evaluation of a rat model of preeclampsia for HELLP syndrome characteristics. J Soc Gynecol Investig 10: 151-153.
65. Tsukimori K, Nakano H, Wake N (2007) Difference in neutrophil superoxide generation during pregnancy between preeclampsia and essential hypertension. Hypertension 9: 1436-1441.
66. Tsukimori K, Komatsu H, Fukushima K, Kaku T, Nakano H, et al. (2008) Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens 21: 477-481.
67. Tanir HM, Sener T, Inal M, Akyuz F, Uzuner K, et al. (2005) Effect of quercetine and glutathione on the level of superoxide dismutase, catalase, malonyldialdehyde, blood pressure and neonatal outcome in a rat model of pre-eclampsia induced by NG-nitro-L-arginine-methyl ester. Eur J Obstet Gynecol Reprod Biol 118: 190-5.
68. Yang X, Guo L, Sun X, Chen X, Tong X (2011) Protective effects of hydrogen-rich saline in preeclampsia rat model. Placenta 32: 681-686.
69. Kilic L, Güven C, Kilinç K (2003) Effect of maternal N-nitro-L-arginine administration on fetal growth and hypoxia-induced changes in newborn rats. Pediatrics International 45: 375-378.
70. Shiraishi M, Haruna M, Matsuzaki M, Ota E, Murayama R, et al. (2013) Relationship between plasma total homocysteine level and dietary caffeine and vitamin B6 intakes in pregnant women. Nurs Health Sci.
71. Laskowska M, Laskowska K, Terbosh M, Oleszczuk J (2013) A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sci Monit 19: 430-437.
72. 12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia. J Obstet Gynaecol Res 37: 45-50.
73. Bibi S, Qureshi, Ahmad M, Qureshi PM, Memon A, et al. (2010) Hyperhomocysteinaemia, vascular related pregnancy complications and the response to vitamin supplementation in pregnant women of Pakistan. J Pak Med Assoc 60: 741-745.
74. Liu HH, Shih TS, Huang HR, Huang SC, Lee LH, et al. (2013) Plasma homocysteine is associated with increased oxidative stress and antioxidant enzyme activity in welders. Scientific World Journal 70487.
75. Kolling J, Scherer EB, da Cunha AA, da Cunha MJ, Wyse AT (2011) Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 11: 67-73.
76. Micle O, Muresan M, Antal L, Bodog F, Bodog A (2012) The influence of homocysteine and oxidative stress on pregnancy outcome. J Med Life 5: 68-73.
77. Pimentel AM, Pereira NR, Costa CA, Mann GE, Cordeiro VS, et al. (2013) L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia. Hypertens Res 36: 783-788.
78. Gohil JT, Patel PK, Gupta P (2011) Evaluation of oxidative stress and antioxidant defence in subjects of preeclampsia. J Obstet Gynaecol India 61: 638-640.
79. Patil SB, Kodliwadmath MV, Kodliwadmath SM (2007) Role of lipid peroxidation and enzymatic antioxidants in pregnancy-induced hypertension. Clin Exp Obstet Gynecol 34: 239-241.
80. Menon J, Rozman R (2007) Oxidative stress, tissue remodeling and regression during amphibian metamorphosis. Comp Biochem Physiol C Toxicol Pharmacol 145: 625-31.
81. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40.
82. Hopkins MH, Fedirko V, Jones DP, Terry PD, Bostick RM (2010) Antioxidant Micronutrients and Biomarkers of Oxidative Stress and Inflammation in Colorectal Adenoma Patients: Results from a Randomized, Controlled Clinical Trial. Cancer Epidemiol Biomarkers Prev 19: 850-858.
83. Jones ML, Mark PJ, Mori TA, Keelan JA, Waddell BJ (2013) Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biol Reprod 88: 37.
84. Bayram M, Taskaya A, Bagriacik EU, Ilhan MN, Yaman M (2012) The effect of maternal serum sFAS/sFASL system on etiopathogenesis of preeclampsia and severe preeclampsia. J Matern Fetal Neonatal Med [Epub ahead of print].
85. Lau SY, Guild SJ, Barrett CJ, Chen Q, McCowan L, et al. (2013) Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol 70: 412-427.
86. Catarino C, Santos-Silva A, Belo L, Rocha-Pereira P, Rocha S, et al. (2012) Inflammatory Disturbances in Preeclampsia: Relationship between Maternal and Umbilical Cord Blood. Journal of Pregnancy 2012: 684384.
87. Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F (2008) Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 2008; 34: 948-951.
88. 12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 28: 190-200.
89. Ellis J, Wennerholm U-B, Bengtsson A, Lilja H, Pettersson A, et al. (2001) Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet GynecolnScand 80: 602-608.
90. Murphy SR, LaMarca BB, Parrish M, Cockrell K, Granger JP (2013) Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-a. Am J Physiol Regul Integr Comp Physiol 304: R130-R135.
91. Ozler A, Turgut A, Sak ME, Evsen MS, Soydinc HE, et al. (2012) Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci 16: 1707-1712.
92. Afshari JT, Ghomian N, Shameli A, Shakeri MT, Fahmidehkar MA, et al. (2005) Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy Childbirth 1: 5-14.
93. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, et al. (2004) Short-and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44: 708-714.
94. Jia D, Heng LJ, Yang RH, Gao GD (2014) Fish oil improves learning impairments of diabetic rats by blocking PI3K/AKT/nuclear factor-kB-mediated inflammatory pathways. Neuroscience 258: 228-237.
95. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res 65: 211-222.
96. Maes M, Christophe A, Bosmans E, Lin A, Neels H (2000) In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatorycy-tokines to psychologic stress. Biol Psychiatry 47: 910-920.
97. Kulkarni AV, Mehendale SS, Yadav HR, Joshi SR (2011c) Reduced placental docosahexaenoic acid levels associated with increased levels of sFlt-1 in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 84: 51-55.
98. Williams AL, Katz D, Ali A, Girard C, Goodman J, et al. (2006) Do essential fatty acids have a role in the treatment of depression? J Affect Disord 93: 117-123. Review.
99. Giussani DA, Camm EJ, Niu Y, Richter HG, Blanco CE, et al. (2012) Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One 7: e31017.
100. Derks JB, Oudijk MA, Torrance HL, Rademaker CM, Benders MJ, et al. (2010) Allopurinol reduces oxidative stress in the ovine fetal cardiovascular system after repeated episodes of ischemia-reperfusion. Pediatr Res 68: 374-380.
101. Zitnanová I, Sumegová K, Simko M, Maruniaková A, Chovanová Z, et al. (2007) Protein carbonyls as a biomarker of foetal-neonatal hypoxic stress. Clin Biochem 40: 567-570.
102. Thompson LP, Al-Hasan Y (2012) Impact of oxidative stress in fetal programming. J Pregnancy 2012: 582748.
103. Chen YC, Sheen JM, Tiao MM, Tain YL, Huang LT (2013) Roles of melatonin in fetal programming in compromised pregnancies. Int J Mol Sci 14: 5380-5401.
104. Namdev S, Vishnu BB, Adhisivam B, Bobby Z (2013) Oxidative stress and antioxidant status among neonates born to mothers with pre-eclampsia and their early outcome. J Matern Fetal Neonatal Med [Epub ahead of print].
105. Orhan H, Onderoglu L, Yücel A, Sahin G (2003) Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 267: 189-195.
106. Negi R, Pande D, Karki K, Kumar A, Khanna RS, et al. (2014) Association of oxidative DNA damage, protein oxidation and antioxidant function with oxidative stress induced cellular injury in pre-eclamptic/eclamptic mothers during fetal circulation. Chem Biol Interact 208: 77-83.
107. Howlader MZ, Parveen S, Tamanna S, Khan TA, Begum F (2009) Oxidative stress and antioxidant status in neonates born to pre-eclamptic mother. J Trop Pediatr 55: 363-367.
108. Dhobale M, Joshi S (2012) Altered maternal micronutrients (folic acid, vitamin B(12)) and omega 3 fatty acids through oxidative stress may reduce neurotrophic factors in preterm pregnancy. J Matern Fetal Neonatal Med 25: 317-323.
109. Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, et al. (2010) Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism. Psychiatry Research 175: 47-53.
110. D'Souza V, Chavan-Gautam P, Joshi S (2013) Counteracting Oxidative Stress in Pregnancy through Modulation of Maternal Micronutrients and Omega-3 Fatty Acids. Curr Med Chem 20: 4777-4783.